• Home
  • NEWS
  • SPORTS
  • ENTERTAINMENT
    • POWER HOUSE
    • MUSIC / VIDEOS
    • MOVIES / TV
  • LIVE
  • Contact Us
Facebook Twitter Instagram
Trending
  • Rihanna, A$AP Rocky attend ‘Iconic’ Beenie Man show in Barbados
  • Beenie Man injures ankle in bike crash — source
  • Will Smith Says He ‘Understands’ If Moviegoers Aren’t Ready to Watch New Film After Oscars Slap
  • Will Smith says bottled rage led him to slap Chris Rock at the Oscars
  • Drake Gifts DJ Khaled with Toilets
  • Soca Invasion Brings Caribbean Culture to Ghana in January
  • SVG days away from exporting first legal shipment of medicinal cannabis
  • Protect yourself and use condom properly- AIDS Secretariat
Magic 103.7
  • Home
  • NEWS
  • SPORTS
  • ENTERTAINMENT
    • POWER HOUSE
    • MUSIC / VIDEOS
    • MOVIES / TV
  • LIVE
  • Contact Us
Magic 103.7
Home»News»Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval
News

Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval

By Magic 103.7 AdminNovember 15, 2021Updated:November 15, 2021No Comments3 Mins Read
Facebook Twitter WhatsApp Reddit Pinterest LinkedIn Telegram Tumblr Email

Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at high risk of progressing to severe illness.” Based on the encouraging results of its trial, Pfizer says it will submit the oral medicine, called Paxlovid, to the U.S. Food and Drug Administration to seek emergency use authorization.

The pill is similar to Merck’s new pill, which was approved in the United Kingdom last week and is being considered for emergency use by the FDA. Like Merck’s pill, Pfizer said its drug showed promising results when administered within five days of the first COVID-19 symptoms.

Both of the antiviral medicines from Pfizer and Merck attack COVID-19 by interfering with its ability to replicate itself.

“These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ lives, reduce the severity of COVID-19 infections, and eliminate up to nine out of ten hospitalizations,” said Albert Bourla, chairman and chief executive officer, Pfizer.

After authorization, Pfizer said its pill could be “prescribed more broadly as an at-home treatment to help reduce illness severity, hospitalizations, and deaths, as well as reduce the probability of infection following exposure, among adults.”

Pfizer-BioNTech Seek Expansion of FDA Booster Approval for All Individuals 18 and Older

Pfizer-BioNTech have submitted a request with the U.S. Food and Drug Administration (FDA) to amend its “emergency use authorization” for a booster dose of the company’s COVID-19 vaccine to include all individuals 18 years of age and older.

The request is based on results from a “Phase 3 randomized, controlled trial evaluating the efficacy and safety” of a booster dose of the vaccine. The study enrolled more than 10,000 participants during a period when the Delta variant was prevalent, Pfizer-BioNTech said in a news release. 

Results from the trial showed that a booster dose administered to those who previously received the Pfizer-BioNTech primary two-dose series demonstrated “a relative vaccine efficacy of 95 percent when compared to those who did not receive a booster,” the companies stated.

A booster, or third dose, of the Pfizer-BioNTech COVID-19 Vaccine is now authorized by the FDA for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with “frequent institutional or occupational exposure” to COVID-19.

Currently, adult recipients of both the Pfizer-BioNTech and Moderna vaccines are eligible for a third shot, or booster, six months after their second injection.

Source: B Health

Share. Facebook Twitter WhatsApp Reddit Pinterest LinkedIn Telegram Tumblr Email
Previous ArticleMan asks date for £3.50 back after she says she doesn’t want to meet again
Next Article 105-year-old runner sets a new 100m world record – but is disappointed she wasn’t even faster

Related Posts

AstraZeneca vaccine: Denmark stops rollout completely

April 14, 2021

Hurricane #Irma death toll hits 10

September 7, 2017

Fertility app Natural Cycles becomes world’s first certified contraception software

August 15, 2017

Comments are closed.

  • Facebook
  • Twitter
  • Instagram
  • YouTube
Listen To Magic 103.7 Live

Trending

Rihanna, A$AP Rocky attend ‘Iconic’ Beenie Man show in Barbados

November 29, 2022

Beenie Man injures ankle in bike crash — source

November 29, 2022

Will Smith Says He ‘Understands’ If Moviegoers Aren’t Ready to Watch New Film After Oscars Slap

November 29, 2022

Will Smith says bottled rage led him to slap Chris Rock at the Oscars

November 29, 2022

Drake Gifts DJ Khaled with Toilets

November 29, 2022
Magic 103.7 - Today's Music Yesterday's Hits
Today’s Music Yesterday’s Hits
Follow Us
  • Facebook
  • Twitter
  • Instagram
  • YouTube
Popular This Week

Rihanna, A$AP Rocky attend ‘Iconic’ Beenie Man show in Barbados

November 29, 2022

Beenie Man injures ankle in bike crash — source

November 29, 2022
Copyright © Magic 103.7 | Designed by Delano Maloney Designs
  • Privacy Policy
  • Contact Us
  • Subscribe

Type above and press Enter to search. Press Esc to cancel.